0.3503
price down icon7.03%   -0.0265
after-market Dopo l'orario di chiusura: .34 -0.0103 -2.94%
loading
Precedente Chiudi:
$0.3768
Aprire:
$0.3703
Volume 24 ore:
490.19K
Relative Volume:
1.47
Capitalizzazione di mercato:
$11.14M
Reddito:
-
Utile/perdita netta:
$-23.36M
Rapporto P/E:
-0.4754
EPS:
-0.7368
Flusso di cassa netto:
-
1 W Prestazione:
-14.64%
1M Prestazione:
-29.07%
6M Prestazione:
-83.48%
1 anno Prestazione:
-88.32%
Intervallo 1D:
Value
$0.3401
$0.3796
Intervallo di 1 settimana:
Value
$0.3401
$0.44
Portata 52W:
Value
$0.3401
$3.89

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name
Nome
Calidi Biotherapeutics Inc
Name
Telefono
(858) 794-9600
Name
Indirizzo
4475 Executive Drive, Suite 200, San Diego
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CLDI's Discussions on Twitter

Confronta CLDI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLDI
Calidi Biotherapeutics Inc
0.3503 13.05M 0 -23.36M 0 -0.7368
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-22 Iniziato H.C. Wainwright Buy
2023-10-09 Iniziato Robert W. Baird Outperform

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

pulisher
May 30, 2025

Calidi Biotherapeutics (NYSE:CLDI) Shares Down 5.3% – Time to Sell? - Defense World

May 30, 2025
pulisher
May 16, 2025

Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Yahoo Finance

May 16, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results And Recent Operational Highlights - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Secures FDA Green Light for Cancer Trial as New CEO Reveals Q1 Financials - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Candel Therapeutics (NASDAQ:CADL) vs. Calidi Biotherapeutics (NYSE:CLDI) Critical Review - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Buys 120,406 Shares of Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

May 04, 2025
pulisher
May 01, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - The Globe and Mail

May 01, 2025
pulisher
Apr 29, 2025

Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 0.3% – Time to Sell? - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Investor’s Delight: Calidi Biotherapeutics Inc (CLDI) Closes Weak at 0.65, Down -6.53 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Calidi (CLDI) Advances Cancer Treatment with IL15 Superagonist a - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Calidi Biotherapeutics Announces IL15 Superagonist as First - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Revolutionary Cancer Treatment Platform Shows Complete Tumor Elimination: First Systemic Delivery Success - Stock Titan

Apr 28, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics (CLDI) Awards Stock Option to New CEO Eri - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Bio's Strategic Move: New CEO Secures 726K Share Options with 4-Year Performance Lock - Stock Titan

Apr 25, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Zealand names former Lilly exec Singh as CSO - BioCentury

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi (CLDI) Appoints New CEO as Eric Poma Assumes Leadership | - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Appoints New CEO Eric Poma - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer Transition And Appointment Of Eric Poma, Ph.D. As CEO And Director - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

New Calidi Bio CEO Brings $400M Funding Success Record: Strategic Shift for Cancer Treatment Pioneer - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor - The Globe and Mail

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24 - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Cancer Breakthrough Alert: Top Oncologist Reveals New FDA-Cleared Stem Cell Therapy Development - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

FDA Green Lights Revolutionary Cancer Treatment: Stem Cells Combined With Virus to Fight Multiple Tumors - Stock Titan

Apr 17, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Cancer Drug Developer Calidi Bio Strengthens Leadership: Renowned Oncologist Takes CMO Role - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Appoints New Chief Medical Officer - TipRanks

Apr 10, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 05, 2025

HighTower Advisors LLC Makes New Investment in Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Apr 05, 2025
pulisher
Apr 01, 2025

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

CLDI stock plunges to 52-week low, hitting $0.57 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Calidi Bio Raises Fresh $3.9M Capital to Advance Clinical Programs - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Calidi Biotherapeutics Cuts Losses by 50% While Expanding Cancer Gene Therapy Trials - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

CLDI stock plunges to 52-week low, hitting $0.57 amid market challenges - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Virtu Financial LLC Buys Shares of 73,448 Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

Calidi Biotherapeutics sinks after pricing $3.9M registered direct offering - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Calidi prices 3.33M shares at 65c in registered direct offering - TipRanks

Mar 28, 2025

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):